[The genetic correction of the mutagenic properties of fotrin by using the interferon inducer larifan in spontaneously metastasizing Lewis lung carcinoma].
Zolotareva
G N
GN
Loginova
N S
NS
Luchinova
I M
IM
Kinzirskiĭ
A S
AS
D000818:Animals; D016587:Antimutagenic Agents / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001388:Aziridines / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000648:ultrastructure; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy* / Q000235:genetics / Q000648:ultrastructure; D002869:Chromosome Aberrations / Q000235:genetics; D004354:Drug Screening Assays, Antitumor; D007369:Interferon Inducers / Q000627:therapeutic use*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009153:Mutagens / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D009930:Organic Chemicals; D013997:Time Factors
D016587:Antimutagenic Agents; D000970:Antineoplastic Agents; D001388:Aziridines; D007369:Interferon Inducers; D009153:Mutagens; D009930:Organic Chemicals; C066530:larifan; C007779:fotrin
Genokorrektsiia mutagennykh svoĭstv fotrina s pomoshch'iu induktora interferona larifana na fone spontanno metastaziruiushcheĭ kartsinomy legkikh L'iuis.